Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
- 6 7 6 7 O
50 7 9 7 9 B-upper_bound
years 10 15 10 15 I-upper_bound

At 0 2 16 18 O
least 3 8 19 24 O
a 9 10 25 26 O
20 11 13 27 29 B-lower_bound
% 13 14 29 30 I-lower_bound
decrease 15 23 31 39 O
in 24 26 40 42 O
FEV1 27 31 43 47 B-clinical_variable
during 32 38 48 54 O
the 39 42 55 58 O
immediate 43 52 59 68 O
response 53 61 69 77 O
following 62 71 78 87 O
inhaled 72 79 88 95 O
antigen 80 87 96 103 O
challenge 88 97 104 113 O

Current 0 7 114 121 O
smokers 8 15 122 129 O
( 16 17 130 131 O
defined 17 24 131 138 O
as 25 27 139 141 O
smoked 28 34 142 148 O
within 35 41 149 155 O
the 42 45 156 159 O
last 46 50 160 164 O
year 51 55 165 169 O
) 55 56 169 170 O
or 57 59 171 173 O
a 60 61 174 175 O
former 62 68 176 182 B-clinical_variable
smoker 69 75 183 189 I-clinical_variable
with 76 80 190 194 I-clinical_variable
a 81 82 195 196 I-clinical_variable
history 83 90 197 204 I-clinical_variable
of 91 93 205 207 O
> 94 95 208 209 O
5 95 96 209 210 B-lower_bound
pack 97 101 211 215 I-lower_bound
years 102 107 216 221 I-lower_bound

Diagnosis 0 9 222 231 O
of 10 12 232 234 O
allergic 13 21 235 243 B-chronic_disease
rhinitis 22 30 244 252 I-chronic_disease
and/or 31 37 253 259 O
mild 38 42 260 264 B-chronic_disease
asthma 43 49 265 271 I-chronic_disease

Documented 0 10 272 282 O
negative 11 19 283 291 O
Tuberculin 20 30 292 302 B-treatment
skin 31 35 303 307 I-treatment
test 36 40 308 312 I-treatment
( 41 42 313 314 I-treatment
PPD 42 45 314 317 I-treatment
) 45 46 317 318 I-treatment
within 47 53 319 325 O
the 54 57 326 329 O
last 58 62 330 334 B-upper_bound
12 63 65 335 337 I-upper_bound
months 66 72 338 344 I-upper_bound
or 73 75 345 347 O
a 76 77 348 349 O
medical 78 85 350 357 O
history 86 93 358 365 O
that 94 98 366 370 O
is 99 101 371 373 O
consistent 102 112 374 384 O
with 113 117 385 389 O
a 118 119 390 391 O
low 120 123 392 395 O
probability 124 135 396 407 O
of 136 138 408 410 O
exposure 139 147 411 419 O
to 148 150 420 422 O
tuberculosis 151 163 423 435 B-chronic_disease
( 164 165 436 437 O
i.e. 165 169 437 441 O
the 170 173 442 445 O
subject 174 181 446 453 O
is 182 184 454 456 O
not 185 188 457 460 O
a 189 190 461 462 O
health 191 197 463 469 O
worker 198 204 470 476 O
, 204 205 476 477 O
has 206 209 478 481 O
not 210 213 482 485 O
traveled 214 222 486 494 O
to 223 225 495 497 O
endemic 226 233 498 505 O
areas 234 239 506 511 O
, 239 240 511 512 O
and 241 244 513 516 O
has 245 248 517 520 O
no 249 251 521 523 O
pre 252 255 524 527 O
- 255 256 527 528 O
existing 256 264 528 536 O
medical 265 272 537 544 O
or 273 275 545 547 O
social 276 282 548 554 O
risk 283 287 555 559 O
factors 288 295 560 567 O
for 296 299 568 571 O
tuberculosis 300 312 572 584 O
) 312 313 584 585 O

Inhaled 0 7 586 593 B-treatment
corticosteroids 8 23 594 609 I-treatment
or 24 26 610 612 O
oral 27 31 613 617 B-treatment
corticosteroids 32 47 618 633 I-treatment
within 48 54 634 640 O
1 55 56 641 642 B-upper_bound
month 57 62 643 648 I-upper_bound
of 63 65 649 651 O
screening 66 75 652 661 O

Major 0 5 662 667 O
health 6 12 668 674 B-chronic_disease
problems 13 21 675 683 I-chronic_disease
such 22 26 684 688 O
as 27 29 689 691 O
autoimmune 30 40 692 702 B-chronic_disease
disease 41 48 703 710 I-chronic_disease
, 48 49 710 711 O
heart 50 55 712 717 B-chronic_disease
disease 56 63 718 725 I-chronic_disease
, 63 64 725 726 O
type 65 69 727 731 B-chronic_disease
I 70 71 732 733 I-chronic_disease
and 72 75 734 737 I-chronic_disease
II 76 78 738 740 I-chronic_disease
diabetes 79 87 741 749 I-chronic_disease
, 87 88 749 750 O
uncontrolled 89 101 751 763 B-chronic_disease
hypertension 102 114 764 776 I-chronic_disease
or 115 117 777 779 O
lung 118 122 780 784 B-chronic_disease
diseases 123 131 785 793 I-chronic_disease
other 132 137 794 799 O
than 138 142 800 804 O
asthma 143 149 805 811 B-chronic_disease
. 149 150 811 812 O
The 151 154 813 816 O
listed 155 161 817 823 O
health 162 168 824 830 O
problems 169 177 831 839 O
are 178 181 840 843 O
definitive 182 192 844 854 O
exclusion 193 202 855 864 O
but 203 206 865 868 O
decisions 207 216 869 878 O
regarding 217 226 879 888 O
major 227 232 889 894 O
health 233 239 895 901 O
problems 240 248 902 910 O
not 249 252 911 914 O
listed 253 259 915 921 O
will 260 264 922 926 O
be 265 267 927 929 O
based 268 273 930 935 O
upon 274 278 936 940 O
the 279 282 941 944 O
judgment 283 291 945 953 O
of 292 294 954 956 O
the 295 298 957 960 O
investigator 299 311 961 973 O

Medication 0 10 974 984 B-treatment
other 11 16 985 990 O
than 17 21 991 995 O
for 22 25 996 999 O
asthma 26 32 1000 1006 B-chronic_disease
, 32 33 1006 1007 O
allergies 34 43 1008 1017 O
or 44 46 1018 1020 O
contraception 47 60 1021 1034 O
( 61 62 1035 1036 O
e.g. 62 66 1036 1040 O
monoamine 67 76 1041 1050 B-treatment
oxidase 77 84 1051 1058 I-treatment
inhibitors 85 95 1059 1069 I-treatment
and 96 99 1070 1073 O
beta 100 104 1074 1078 B-treatment
- 104 105 1078 1079 I-treatment
adrenergic 105 115 1079 1089 I-treatment
antagonists 116 127 1090 1101 I-treatment
in 128 130 1102 1104 O
any 131 134 1105 1108 O
form 135 139 1109 1113 O
) 139 140 1113 1114 O

No 0 2 1115 1117 O
pre 3 6 1118 1121 O
- 6 7 1121 1122 O
existing 7 15 1122 1130 O
chronic 16 23 1131 1138 B-chronic_disease
infectious 24 34 1139 1149 I-chronic_disease
disease 35 42 1150 1157 I-chronic_disease

Obesity 0 7 1158 1165 B-chronic_disease
as 8 10 1166 1168 O
defined 11 18 1169 1176 O
by 19 21 1177 1179 O
a 22 23 1180 1181 O
Body 24 28 1182 1186 B-bmi
Mass 29 33 1187 1191 I-bmi
Index 34 39 1192 1197 I-bmi
( 40 41 1198 1199 I-bmi
BMI 41 44 1199 1202 I-bmi
) 44 45 1202 1203 I-bmi
> 46 47 1204 1205 O
30 47 49 1205 1207 B-lower_bound

Pre 0 3 1208 1211 O
- 3 4 1211 1212 O
albuterol 4 13 1212 1221 O
forced 14 20 1222 1228 O
expiratory 21 31 1229 1239 B-clinical_variable
volume 32 38 1240 1246 I-clinical_variable
in 39 41 1247 1249 I-clinical_variable
the 42 45 1250 1253 I-clinical_variable
first 46 51 1254 1259 I-clinical_variable
second 52 58 1260 1266 I-clinical_variable
( 59 60 1267 1268 I-clinical_variable
FEV1 60 64 1268 1272 I-clinical_variable
) 64 65 1272 1273 I-clinical_variable
of 66 68 1274 1276 O
> 69 70 1277 1278 O
70 70 72 1278 1280 B-lower_bound
% 72 73 1280 1281 I-lower_bound
predicted 74 83 1282 1291 O

Pregnant 0 8 1292 1300 B-pregnancy

Safety 0 6 1301 1307 O
laboratory 7 17 1308 1318 O
assessments 18 29 1319 1330 O
within 30 36 1331 1337 O
normal 37 43 1338 1344 O
ranges 44 50 1345 1351 O
( 51 52 1352 1353 O
labs 52 56 1353 1357 O
to 57 59 1358 1360 O
include 60 67 1361 1368 O
complete 68 76 1369 1377 O
blood 77 82 1378 1383 O
count 83 88 1384 1389 O
with 89 93 1390 1394 O
differential 94 106 1395 1407 O
, 106 107 1407 1408 O
blood 108 113 1409 1414 B-clinical_variable
urea 114 118 1415 1419 I-clinical_variable
nitrogen 119 127 1420 1428 I-clinical_variable
, 127 128 1428 1429 O
creatinine 129 139 1430 1440 B-clinical_variable
, 139 140 1440 1441 O
Prothrombin 141 152 1442 1453 B-clinical_variable
time 153 157 1454 1458 I-clinical_variable
, 157 158 1458 1459 O
Partial 159 166 1460 1467 B-clinical_variable
Thromboplastin 167 181 1468 1482 I-clinical_variable
Time 182 186 1483 1487 I-clinical_variable
and 187 190 1488 1491 O
platelet 191 199 1492 1500 B-clinical_variable
count 200 205 1501 1506 I-clinical_variable
) 205 206 1506 1507 O

Unstable 0 8 1508 1516 O
asthma 9 15 1517 1523 B-chronic_disease
as 16 18 1524 1526 O
indicated 19 28 1527 1536 O
by 29 31 1537 1539 O
self 32 36 1540 1544 O
report 37 43 1545 1551 O
of 44 46 1552 1554 O
increased 47 56 1555 1564 O
symptoms 57 65 1565 1573 O
or 66 68 1574 1576 O
increased 69 78 1577 1586 O
beta 79 83 1587 1591 B-treatment
- 83 84 1591 1592 I-treatment
agonist 84 91 1592 1599 I-treatment
use 92 95 1600 1603 O
over 96 100 1604 1608 O
the 101 104 1609 1612 O
2 105 106 1613 1614 B-lower_bound
weeks 107 112 1615 1620 I-lower_bound
preceding 113 122 1621 1630 O
the 123 126 1631 1634 O
screening 127 136 1635 1644 O
visit 137 142 1645 1650 O

Upper 0 5 1651 1656 B-chronic_disease
or 6 8 1657 1659 I-chronic_disease
lower 9 14 1660 1665 I-chronic_disease
respiratory 15 26 1666 1677 I-chronic_disease
infection 27 36 1678 1687 I-chronic_disease
within 37 43 1688 1694 O
1 44 45 1695 1696 B-upper_bound
month 46 51 1697 1702 I-upper_bound
of 52 54 1703 1705 O
screening 55 64 1706 1715 O

Use 0 3 1716 1719 O
of 4 6 1720 1722 O
an 7 9 1723 1725 O
investigational 10 25 1726 1741 B-treatment
drug 26 30 1742 1746 I-treatment
within 31 37 1747 1753 O
30 38 40 1754 1756 B-upper_bound
days 41 45 1757 1761 I-upper_bound
of 46 48 1762 1764 O
entering 49 57 1765 1773 O
the 58 61 1774 1777 O
study 62 67 1778 1783 O

Women 0 5 1784 1789 B-gender
of 6 8 1790 1792 O
child 9 14 1793 1798 O
- 14 15 1798 1799 O
bearing 15 22 1799 1806 O
potential 23 32 1807 1816 O
( 33 34 1817 1818 O
WCBP 34 38 1818 1822 O
) 38 39 1822 1823 O
must 40 44 1824 1828 O
have 45 49 1829 1833 O
a 50 51 1834 1835 O
negative 52 60 1836 1844 B-pregnancy
urine 61 66 1845 1850 I-pregnancy
pregnancy 67 76 1851 1860 I-pregnancy
test 77 81 1861 1865 O
( 82 83 1866 1867 O
urine 83 88 1867 1872 O
HCG 89 92 1873 1876 O
) 92 93 1876 1877 O
within 94 100 1878 1884 O
48 101 103 1885 1887 B-upper_bound
hours 104 109 1888 1893 I-upper_bound
of 110 112 1894 1896 O
the 113 116 1897 1900 O
methacholine 117 129 1901 1913 B-treatment
challenge 130 139 1914 1923 O
at 140 142 1924 1926 O
Visit 143 148 1927 1932 O
2 149 150 1933 1934 O
, 150 151 1934 1935 O
within 152 158 1936 1942 O
48 159 161 1943 1945 O
hours 162 167 1946 1951 O
of 168 170 1952 1954 O
the 171 174 1955 1958 O
inhaled 175 182 1959 1966 O
allergen 183 191 1967 1975 O
challenge 192 201 1976 1985 O
at 202 204 1986 1988 O
V3 205 207 1989 1991 O
and 208 211 1992 1995 O
on 212 214 1996 1998 O
the 215 218 1999 2002 O
day 219 222 2003 2006 O
of 223 225 2007 2009 O
the 226 229 2010 2013 O
segmental 230 239 2014 2023 O
allergen 240 248 2024 2032 O
challenge 249 258 2033 2042 O
on 259 261 2043 2045 O
Visit 262 267 2046 2051 O
5 268 269 2052 2053 O
. 269 270 2053 2054 O
WCBP 271 275 2055 2059 O
must 276 280 2060 2064 O
agree 281 286 2065 2070 B-contraception_consent
to 287 289 2071 2073 I-contraception_consent
use 290 293 2074 2077 I-contraception_consent
a 294 295 2078 2079 I-contraception_consent
reliable 296 304 2080 2088 I-contraception_consent
method 305 311 2089 2095 I-contraception_consent
of 312 314 2096 2098 I-contraception_consent
birth 315 320 2099 2104 I-contraception_consent
control 321 328 2105 2112 I-contraception_consent
for 329 332 2113 2116 O
the 333 336 2117 2120 O
duration 337 345 2121 2129 O
of 346 348 2130 2132 O
the 349 352 2133 2136 O
study 353 358 2137 2142 O
( 359 360 2143 2144 O
reliable 360 368 2144 2152 O
methods 369 376 2153 2160 O
of 377 379 2161 2163 O
birth 380 385 2164 2169 O
control 386 393 2170 2177 O
can 394 397 2178 2181 O
include 398 405 2182 2189 O
abstinence 406 416 2190 2200 B-contraception_consent
, 416 417 2200 2201 O
barrier 418 425 2202 2209 B-contraception_consent
methods 426 433 2210 2217 I-contraception_consent
, 433 434 2217 2218 O
oral 435 439 2219 2223 B-contraception_consent
contraceptives 440 454 2224 2238 I-contraception_consent
, 454 455 2238 2239 O
injection 456 465 2240 2249 B-contraception_consent
contraceptives 466 480 2250 2264 I-contraception_consent
or 481 483 2265 2267 O
skin 484 488 2268 2272 B-contraception_consent
absorption 489 499 2273 2283 I-contraception_consent
contraceptives 500 514 2284 2298 I-contraception_consent
) 514 515 2298 2299 O

has 0 3 2300 2303 O
a 4 5 2304 2305 O
planned 6 13 2306 2313 B-pregnancy
pregnancy 14 23 2314 2323 I-pregnancy
during 24 30 2324 2330 O
the 31 34 2331 2334 O
course 35 41 2335 2341 O
of 42 44 2342 2344 O
the 45 48 2345 2348 O
study 49 54 2349 2354 O

lactating 0 9 2355 2364 O
females 10 17 2365 2372 B-gender

